Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Trial Comparing Chemotherapy With Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma

NCT02539537 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT02539537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02539537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Trial Comparing Chemotherapy With Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Completed
Start date
October 23, 2015
Completion date
September 25, 2023
Enrollment
171 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, pancreatic cancer